Frequently Asked Questions Is GHK-Cu peptide injection FDA-approved for clinical use
Regulatory status (as of publication): Not approved by the FDA, EMA, or any other regulatory authority for any indication
The medication should never be taken in the evening because the stimulant properties cause insomnia
Maintenance is needed through continued therapy, skincare, and sun protection
Document any immediate post-injection monitoring
Based on the displayed structures, and in particular with that of the glutathione conjugate of etacrynic acid [132], which is itself a Michael acceptor, it is well conceivable that glutathione acrylate can dock into the glutathione activating pocket of the GST enzymes and irreversibly bind to the essential tyrosine phenolate function, thus inactivating the enzyme